FdaApplication
ANDA 214727
Identifiers
- fda_app_no: ANDA214727
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2021-03-18 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| POTASSIUM CHLORIDE 10MEQ | POTASSIUM CHLORIDE | 745MG/100ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 10MEQ | POTASSIUM CHLORIDE | 14.9MG/ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 20MEQ | POTASSIUM CHLORIDE | 1.49GM/100ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 20MEQ | POTASSIUM CHLORIDE | 29.8MG/ML | INJECTABLE;INJECTION |
| POTASSIUM CHLORIDE 40MEQ | POTASSIUM CHLORIDE | 2.98GM/100ML | INJECTABLE;INJECTION |
5 products